We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
"One Size Does Not Fit All" in Newly Diagnosed Multiple Myeloma.
- Authors
Stewart, Patricia
- Abstract
The article offers information about the Randomized, Phase III DETERMINATION trial which showed the superiority of autologous stem cell transplantation (ASCT)-based first-line therapy with respect to progression-free survival among eligible patients with newly diagnosed myeloma. It mentions that study demonstrates that ASCT still has a place in the care of patients with multiple myeloma.
- Subjects
MULTIPLE myeloma; MEDICAL personnel
- Publication
Oncology Practice Management, 2022, Vol 12, Issue 9, p1
- ISSN
2164-4403
- Publication type
Article